Appia Rare Earths & Uranium Corp. largest revenue segment is Recombinant Therapeutic Proteins, at a revenue of 52,744,000 in the most earnings release.For geography, Italy is the primary market for Appia Rare Earths & Uranium Corp., at a revenue of 22,513,000.